Roslin Cells Ltd has reached an agreement with Pfizer Inc giving the US multinational access to its pluripotent stem cell lines with a view to assessing their potential for specific clinical therapies. Financial terms were not disclosed. ---Subscribe to MedNous to access this article--- Regenerative Medicine
